A PHASE-II STUDY OF VP-16-IFOSFAMIDE-CISPLATIN (VIP) PLUS EARLY CONCURRENT THORACIC IRRADIATION (TI) FOR PREVIOUSLY UNTREATED LIMITED SMALL-CELL LUNG-CANCER (SCLC)

Authors
WOO IS PARK YS PARK YI LEE JA AHN JS BAE HS KIM WS PARK KC KIM HJ AHN YC
Citation
Is. Woo et al., A PHASE-II STUDY OF VP-16-IFOSFAMIDE-CISPLATIN (VIP) PLUS EARLY CONCURRENT THORACIC IRRADIATION (TI) FOR PREVIOUSLY UNTREATED LIMITED SMALL-CELL LUNG-CANCER (SCLC), Annals of oncology, 9, 1998, pp. 500-500
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
500 - 500
Database
ISI
SICI code
0923-7534(1998)9:<500:APSOV(>2.0.ZU;2-D